Jake Barnett

28%
Flag icon
Anti-D (Rh) immunoglobulin and rituximab are second-line therapies for ITP. Anti-D (Rh) immunoglobulin and IVIG act as “decoys” so that WBCs will recognize them instead of IgG on platelets.
First Aid for the USMLE Step 2 CK, Eleventh Edition
by Tao Le
Rate this book
Clear rating
Open Preview